Pentoxifylline improves the oxygenation and radiation response of BA1112 rat rhabdomyosarcomas and EMT6 mouse mammary carcinomas

International Journal of Cancer

Volumn 90, Issue 5, 2000, Pages 256-264

  Collingridge, David R ^a   Rockwell, Sara ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pentoxifylline; Radiosensitization; Tumor oxygenation

Indexed keywords

PENTOXIFYLLINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; HYPOXEMIA; HYPOXIA; MOUSE; NONHUMAN; OXYGEN BREATHING; OXYGEN TISSUE LEVEL; OXYGENATION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIZATION; RAT; RHABDOMYOSARCOMA; TREATMENT OUTCOME;

ANIMALS; ANOXIA; CARCINOMA; CELL SURVIVAL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; OXYGEN; PENTOXIFYLLINE; PRESSURE; RADIATION-PROTECTIVE AGENTS; RADIATION-SENSITIZING AGENTS; RATS; RHABDOMYOSARCOMA; TUMOR CELLS, CULTURED;

EID: 0033764934     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001020)90:5<256::AID-IJC2>3.0.CO;2-R     Document Type: Article

References (44)

1. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
2. Enhancement of bioreductive drug toxicity in murine tumors by inhibition of the activity of nitric oxide synthase
3. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain
4. Nicotinamide, fluosol-DA and carbogen: A strategy to reoxygenate acutely and chronically hypoxic cells in vivo
5. Modulation of tumor oxygenation and radiosensitivity by a perfluorooctylbromide emulsion
6. Die ergebnisse der gasbehandlung bsartiger geschwlste beim menschen
7. 2 histography
8. 2, microcirculatory function and radiosensitivity
9. The effect of nicotinamide on microregional blood flow within tumors assessed using laser doppler probes
10. DNA damage and repair in tumor and non-tumor tissues of mice induced by nicotinamide
11. Nicotinamide as a repair inhibitor in vivo: Studies using single and fractionated x-ray doses in mouse skin and kidneys
12. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated x-ray treatments
13. Clinical results of hypoxic cell radiosensitization from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide
14. Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: Feasibility and toxicity
15. Phase I study of combined radiation response modifiers employing hydroxyurea and pentoxifylline for treatment of glioblastoma
16. Phase I/II studies with pentoxifylline as a potential hypoxic cell modifier
17. Pentoxifylline: A biochemical profile
18. Pentoxifylline: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy
19. Nicotinamide and pentoxifylline increase human leucocyte filterability: A possible mechanism for reduction of acute hypoxia
20. Effect of pentoxifylline on rabbit pulmonary circulation: Influence of age and vasomotor tone
21. Analysis of responses to pentoxifylline in the pulmonary vascular bed of the cat
22. Inhibition of tumor necrosis factor-alpha secretion by pentoxifylline in advanced cancer patients with abnormally high blood levels of tumor necrosis factor-alpha
23. Suppressive effects of pentoxifylline on natural killer cell activity
24. The effects of pentoxifylline on the generation of human lymphokine-activated killer cell cytotoxicity
25. Pentoxifylline: Its pharmacokinetics and ability to improve perfusion and radiosensitivity in mice
26. 2 in a manner compatible with its ability to increase relative tumor perfusion
27. Improved tumor oxygenation and radiosensitization by combination with nicotinamide and pentoxifylline
28. Changes in tumor blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline
29. Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline
30. Tumor oxygenation and radiosensitization by pentoxifylline and a perflubron emulsion/carbogen breathing
31. Effect of pentoxifylline on radiation-induced G2-phase delay and radiosensitivity of human colon and cervical cancer
32. Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines
33. Pentoxifylline potentiates the antitumor effect of cisplatin and etoposide on human lung cancer cell lines
34. In vitro effects of pentoxifylline and doxorubicin on cell survival and DNA damage in sensitive and MDR-P388 leukemia cells
35. Effect of a perfluorocarbon emulsion on the radiation response of BA1112 rhabdomyosarcoma
36. In vivo-in vitro tumor systems: New models for studying the response of tumors to therapy
37. Measurement of tumor oxygenation: A comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor
38. Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data
39. Tumor hypoxia: Its impact on cancer therapy
40. Repair of potentially lethal damage in vivo in solid tumor cells after x-irradiation
41. Enhancement of radiation response on human carcinoma cells in culture by pentoxifylline
42. Wild-type p53 is a cell cycle checkpoint determinant following irradiation
43. Requirement for p53 and p21 to sustain G2 arrest after DNA damage
44. Role of wild type p53 in the G2 phase: Regulation of the gamma-irradiation-induced delay and DNA repair